Efficient production of Moloney murine leukemia virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein
M. Caruso, S. Roy, K. Ghani, P. O. de Campos-Lima
This paper develops a scalable platform for producing SARS-CoV-2 spike protein pseudotyped MLV-like particles, showing efficient incorporation of a truncated spike protein into VLPs.
bioRxiv · Sep 16, 2020Microbiology